We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Skip to main content
Log in

National bowel cancer screening cost effective in Australia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 Australian dollars

References

  1. Lew J-B, et al. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study. The Lancet Public Health : 26 Jun 2017. Available from: URL: http://dx.doi.org/10.1016/S2468-2667(17)30105-6.

  2. Kuipers EJ, et al. Colorectal cancer screening in Australia. The Lancet Public Health : 26 Jun 2017. Available from: URL: http://dx.doi.org/10.1016/S2468-2667(17)30121-4.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

National bowel cancer screening cost effective in Australia. PharmacoEcon Outcomes News 781, 24 (2017). https://doi.org/10.1007/s40274-017-4116-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4116-3

Navigation